167 related articles for article (PubMed ID: 33990627)
1. HNF1A regulates colorectal cancer progression and drug resistance as a downstream of POU5F1.
Fujino S; Miyoshi N; Ito A; Yasui M; Matsuda C; Ohue M; Uemura M; Mizushima T; Doki Y; Eguchi H
Sci Rep; 2021 May; 11(1):10363. PubMed ID: 33990627
[TBL] [Abstract][Full Text] [Related]
2. HNF1A is a novel oncogene that regulates human pancreatic cancer stem cell properties.
Abel EV; Goto M; Magnuson B; Abraham S; Ramanathan N; Hotaling E; Alaniz AA; Kumar-Sinha C; Dziubinski ML; Urs S; Wang L; Shi J; Waghray M; Ljungman M; Crawford HC; Simeone DM
Elife; 2018 Aug; 7():. PubMed ID: 30074477
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA HNF1A-AS1 indicates a poor prognosis of colorectal cancer and promotes carcinogenesis via activation of the Wnt/β-catenin signaling pathway.
Zhang X; Xiong Y; Tang F; Bian Y; Chen Y; Zhang F
Biomed Pharmacother; 2017 Dec; 96():877-883. PubMed ID: 29145164
[TBL] [Abstract][Full Text] [Related]
4. Hepatocyte nuclear factor 1A (HNF1A) as a possible tumor suppressor in pancreatic cancer.
Luo Z; Li Y; Wang H; Fleming J; Li M; Kang Y; Zhang R; Li D
PLoS One; 2015; 10(3):e0121082. PubMed ID: 25793983
[TBL] [Abstract][Full Text] [Related]
5. HNF1A regulates oxaliplatin resistance in pancreatic cancer by targeting 53BP1.
Xia R; Hu C; Ye Y; Zhang X; Li T; He R; Zheng S; Wen X; Chen R
Int J Oncol; 2023 Apr; 62(4):. PubMed ID: 36825600
[TBL] [Abstract][Full Text] [Related]
6. Pregnane X receptor is associated with unfavorable survival and induces chemotherapeutic resistance by transcriptional activating multidrug resistance-related protein 3 in colorectal cancer.
Dong Y; Wang Z; Xie GF; Li C; Zuo WW; Meng G; Xu CP; Li JJ
Mol Cancer; 2017 Mar; 16(1):71. PubMed ID: 28356150
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA HNF1A-AS is upregulated and promotes cell proliferation and metastasis in nasopharyngeal carcinoma.
Zhuang K; Wu Q; Jin CS; Yuan HJ; Cheng JZ
Cancer Biomark; 2016; 16(2):291-300. PubMed ID: 26756620
[TBL] [Abstract][Full Text] [Related]
8. KHDRBS3 promotes multi-drug resistance and anchorage-independent growth in colorectal cancer.
Ukai S; Sakamoto N; Taniyama D; Harada K; Honma R; Maruyama R; Naka K; Hinoi T; Takakura Y; Shimizu W; Ohdan H; Yasui W
Cancer Sci; 2021 Mar; 112(3):1196-1208. PubMed ID: 33423358
[TBL] [Abstract][Full Text] [Related]
9. The long non-coding RNA HNF1A-AS1 regulates proliferation and metastasis in lung adenocarcinoma.
Wu Y; Liu H; Shi X; Yao Y; Yang W; Song Y
Oncotarget; 2015 Apr; 6(11):9160-72. PubMed ID: 25863539
[TBL] [Abstract][Full Text] [Related]
10. circHIPK3 promotes oxaliplatin-resistance in colorectal cancer through autophagy by sponging miR-637.
Zhang Y; Li C; Liu X; Wang Y; Zhao R; Yang Y; Zheng X; Zhang Y; Zhang X
EBioMedicine; 2019 Oct; 48():277-288. PubMed ID: 31631038
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of microRNA-135b and microRNA-182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathway.
Liu B; Liu Y; Zhao L; Pan Y; Shan Y; Li Y; Jia L
Mol Carcinog; 2017 Dec; 56(12):2669-2680. PubMed ID: 28767179
[TBL] [Abstract][Full Text] [Related]
12. The deoxycholic acid targets miRNA-dependent CAC1 gene expression in multidrug resistance of human colorectal cancer.
Kong Y; Bai PS; Sun H; Nan KJ; Chen NZ; Qi XG
Int J Biochem Cell Biol; 2012 Dec; 44(12):2321-32. PubMed ID: 22903020
[TBL] [Abstract][Full Text] [Related]
13. The HNF1α-regulated lncRNA HNF1A-AS1 reverses the malignancy of hepatocellular carcinoma by enhancing the phosphatase activity of SHP-1.
Ding CH; Yin C; Chen SJ; Wen LZ; Ding K; Lei SJ; Liu JP; Wang J; Chen KX; Jiang HL; Zhang X; Luo C; Xie WF
Mol Cancer; 2018 Feb; 17(1):63. PubMed ID: 29466992
[TBL] [Abstract][Full Text] [Related]
14. Hepatocyte nuclear factor HNF1A is a potential regulator in shaping the super-enhancer landscape in colorectal cancer liver metastasis.
Cai C; Bi D; Bick G; Wei Q; Liu H; Lu L; Zhang X; Qin H
FEBS Lett; 2021 Dec; 595(24):3056-3071. PubMed ID: 34719039
[TBL] [Abstract][Full Text] [Related]
15. Eukaryotic initiation factor 4A2 promotes experimental metastasis and oxaliplatin resistance in colorectal cancer.
Chen ZH; Qi JJ; Wu QN; Lu JH; Liu ZX; Wang Y; Hu PS; Li T; Lin JF; Wu XY; Miao L; Zeng ZL; Xie D; Ju HQ; Xu RH; Wang F
J Exp Clin Cancer Res; 2019 May; 38(1):196. PubMed ID: 31088567
[TBL] [Abstract][Full Text] [Related]
16. HNF1A/CASC2 regulates pancreatic cancer cell proliferation through PTEN/Akt signaling.
Yu Y; Liang S; Zhou Y; Li S; Li Y; Liao W
J Cell Biochem; 2019 Mar; 120(3):2816-2827. PubMed ID: 28865121
[TBL] [Abstract][Full Text] [Related]
17. Nuclear factor I/B promotes colorectal cancer cell proliferation, epithelial-mesenchymal transition and 5-fluorouracil resistance.
Liu Z; Chen J; Yuan W; Ruan H; Shu Y; Ji J; Wu L; Tang Q; Zhou Z; Zhang X; Cheng Y; He S; Shu X
Cancer Sci; 2019 Jan; 110(1):86-98. PubMed ID: 30320939
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of DJ-1 enhances colorectal cancer cell proliferation through the cyclin-D1/MDM2-p53 signaling pathway.
Zhu X; Luo C; Lin K; Bu F; Ye F; Huang C; Luo H; Huang J; Zhu Z
Biosci Trends; 2020 May; 14(2):83-95. PubMed ID: 32132307
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of PKM2 and GLS1 expression can significantly reverse oxaliplatin-resistance in colorectal cancer cells.
Lu WQ; Hu YY; Lin XP; Fan W
Oncotarget; 2017 Jul; 8(27):44171-44185. PubMed ID: 28498807
[TBL] [Abstract][Full Text] [Related]
20. SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF.
Saeinasab M; Bahrami AR; González J; Marchese FP; Martinez D; Mowla SJ; Matin MM; Huarte M
J Exp Clin Cancer Res; 2019 Apr; 38(1):172. PubMed ID: 31014355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
